Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000518653 | SCV000614760 | uncertain significance | not specified | 2016-10-17 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000728228 | SCV000855774 | uncertain significance | not provided | 2017-07-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001241622 | SCV001414652 | likely benign | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A2; Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B2; Autosomal recessive limb-girdle muscular dystrophy type 2N | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000728228 | SCV003809733 | uncertain significance | not provided | 2019-07-08 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000728228 | SCV004702835 | likely benign | not provided | 2023-12-01 | criteria provided, single submitter | clinical testing | POMT2: BS2 |